Evaluation of the safety of a coumarin–troxerutin combination
✍ Scribed by Professor Rudolf Bruppacher; Bernd Rieckemann; Belal Naser-Hijazi; Peter Wüstenberg
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 102 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1053-8569
No coin nor oath required. For personal study only.
✦ Synopsis
Concerns about liver reactions reported for coumarin preparations prompted a re-evaluation of the combination of coumarin with troxerutin, widely used since 1971 in Germany. No evidence of liver toxicity could be found in available clinical research data. We estimated the number of coincidental cases of unexplained clinically apparent liver disease expected to arise during the patient treatment time on the basis of sales and the maximal recommended daily dosage. A comparison to the number of spontaneous reports yielded reassuring results.
📜 SIMILAR VOLUMES
## Abstract ## Objectives/Hypothesis: The depth of the frontal sinus was measured using axial computed tomography (CT) images to examine the safety of frontal sinus trephination at selected distances from the midline. ## Study Design: Review of 200 sinus CT scans. ## Methods: Two hundred sinus
Synthetic coumarin (benzopyrone) was launched in France in 1988 for the adjuvant therapy of lymphoedema of the upper limb following radiosurgical treatment of breast cancer. Further to the reporting of hepatic reactions, a national survey has been carried out. The survey dealt with 22 cases reported
This critique refutes Zador's claim [1976] that Alcohol Safety Action Projects, as large scale social programs have been ineffective. The discussion takes issue with Zador's comparison groups, statistical design, statistical methods, and use of lZ-month fatality totals for data analysis. In addition